Search research articles
Contact Us
Filters
Showing results (1-10 of 7) with videos related to
Page
of 1
Sort By:
Nature Reviews. Drug Discovery
|
December 3, 2016
Drug launch curves in the modern era
Seth Robey, Frank S David
Proceedings of the National Academy of Sciences of the United States of America
|
April 18, 2012
Allosteric gating mechanism underlies the flexible gating of KCNQ1 potassium channels
Jeremiah D Osteen, Rene Barro-Soria, Seth Robey, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
November 24, 2025
Modeling amyloid plaque turnover dynamics improves characterization of drug effects
Eline van Maanen, Seth Robey, Idriss Bennacef, et al.
Ebiomedicine
|
October 1, 2022
Accelerating model-informed decisions for COVID-19 vaccine candidates using a model-based meta-analysis approach
Bhargava Kandala, Nele Plock, Akshita Chawla, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
March 4, 2023
A comprehensive regulatory and industry review of modeling and simulation practices in oncology clinical drug development
Ana Ruiz-Garcia, Paul Baverel, Dean Bottino, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Drug Development
Jonathan A Sugam, Seth Robey, Sokreine Suon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2018
Pembrolizumab Plus Pegylated Interferon alfa-2b or Ipilimumab for Advanced Melanoma or Renal Cell Carcinoma: Dose-Finding Results from the Phase Ib KEYNOTE-029 Study
Michael B Atkins, F Stephen Hodi, John A Thompson, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 7) with videos related to
Sort By:
Page
of 1
Nature Reviews. Drug Discovery
|
December 3, 2016
Drug launch curves in the modern era
Seth Robey, Frank S David
Proceedings of the National Academy of Sciences of the United States of America
|
April 18, 2012
Allosteric gating mechanism underlies the flexible gating of KCNQ1 potassium channels
Jeremiah D Osteen, Rene Barro-Soria, Seth Robey, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
November 24, 2025
Modeling amyloid plaque turnover dynamics improves characterization of drug effects
Eline van Maanen, Seth Robey, Idriss Bennacef, et al.
Ebiomedicine
|
October 1, 2022
Accelerating model-informed decisions for COVID-19 vaccine candidates using a model-based meta-analysis approach
Bhargava Kandala, Nele Plock, Akshita Chawla, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
March 4, 2023
A comprehensive regulatory and industry review of modeling and simulation practices in oncology clinical drug development
Ana Ruiz-Garcia, Paul Baverel, Dean Bottino, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Drug Development
Jonathan A Sugam, Seth Robey, Sokreine Suon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2018
Pembrolizumab Plus Pegylated Interferon alfa-2b or Ipilimumab for Advanced Melanoma or Renal Cell Carcinoma: Dose-Finding Results from the Phase Ib KEYNOTE-029 Study
Michael B Atkins, F Stephen Hodi, John A Thompson, et al.
Page
of 1